Novartis’s $9.7 Billion Purchase Includes Novel PCSK9 Inhibitor
Novartis’s $9.7 Billion Purchase Includes Novel PCSK9 Inhibitor
The pharmaceutical firm is buying The Medicines Company, which recently devoted its efforts into developing the cholesterol-lowering medication.
Novartis’s $9.7 Billion Purchase Includes Novel PCSK9 Inhibitor
Novartis’s $9.7 Billion Purchase Includes Novel PCSK9 Inhibitor

The pharmaceutical firm is buying The Medicines Company, which recently devoted its efforts into developing the cholesterol-lowering medication.

The pharmaceutical firm is buying The Medicines Company, which recently devoted its efforts into developing the cholesterol-lowering medication.

mergers and acquisition
UCB Cuts $2.1 Billion Deal to Acquire Ra Pharma
UCB Cuts $2.1 Billion Deal to Acquire Ra Pharma
Catherine Offord | Oct 14, 2019
The move will allow the Belgium-headquartered biopharmaceutical giant to boost its work on treatments for rare diseases.
Bristol-Myers Squibb to Buy Celgene for $74 Billion
Bristol-Myers Squibb to Buy Celgene for $74 Billion
Catherine Offord | Jan 3, 2019
The deal between the two biopharmaceutical giants will boost the purchaser’s cancer drug portfolio.
Gilead to Pay Nearly $12B for CAR T-Cell Company
Gilead to Pay Nearly $12B for CAR T-Cell Company
Jef Akst | Aug 28, 2017
The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.
Thermo Fisher to Buy Patheon for $5.2 Billion
Thermo Fisher to Buy Patheon for $5.2 Billion
Aggie Mika | May 16, 2017
The scientific supply giant seeks to expand into biopharma development and manufacturing.  
Monsanto and Bayer Announce Approval of Massive Merger
Monsanto and Bayer Announce Approval of Massive Merger
Bob Grant | Dec 13, 2016
On Tuesday, shareholders at the agribusiness giant approved the $66 billion deal with the European pharmaceutical firm.
Novartis Buys US Drugmaker for Up To $665 Million
Novartis Buys US Drugmaker for Up To $665 Million
Tracy Vence | Nov 22, 2016
The Swiss pharma giant is acquiring Oklahoma-based Selexys Pharmaceuticals, a maker of drugs for inflammatory and thrombotic diseases.
Allergan’s Buying Spree Rolls On
Allergan’s Buying Spree Rolls On
Bob Grant | Sep 21, 2016
The Ireland-based pharma company makes a $1.7 billion offer to acquire Tobira Therapeutics, a US firm developing liver disease drugs.
Allergan Set to Buy Vitae
Allergan Set to Buy Vitae
Bob Grant | Sep 16, 2016
The Irish drugmaker has made a $639 million dollar offer to buy the US-based biopharma.
Bayer Looks to Buy Monsanto
Bayer Looks to Buy Monsanto
Bob Grant | Sep 14, 2016
The US agribusiness behemoth agreed to a $57 billion buyout offer from the European pharmaceutical giant.
Pfizer to Buy Medivation for $14 Billion
Pfizer to Buy Medivation for $14 Billion
Bob Grant | Aug 22, 2016
The pharma giant is purchasing the San Francisco–based cancer drugmaker to boost its oncology portfolio.
TS Picks: June 6, 2016
TS Picks: June 6, 2016
Jef Akst | Jun 6, 2016
American Society of Clinical Oncology meeting edition 
$1.5 Billion Pharma Buyout for Leukemia Drug
$1.5 Billion Pharma Buyout for Leukemia Drug
Jef Akst | Jun 1, 2016
Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.
Thermo Fisher to Acquire FEI
Thermo Fisher to Acquire FEI
Tracy Vence | Jun 1, 2016
In a $4.2 billion deal, the science equipment giant is buying the Hillsboro, Oregon-based electron microscope maker.
Pfizer Scoops Anacor for $5.3 Billion
Pfizer Scoops Anacor for $5.3 Billion
Bob Grant | May 17, 2016
The acquisition-hungry pharmaceutical firm is purchasing the California-based eczema gel maker.
Pfizer-Allergan Merger Scrapped
Pfizer-Allergan Merger Scrapped
Bob Grant | Apr 7, 2016
A move by the US federal government to close tax loopholes that encourage “tax inversions” likely spooked the companies out of the multibillion dollar deal.
Former Affymetrix Employees Fail to Stop Thermo Fisher Takeover
Former Affymetrix Employees Fail to Stop Thermo Fisher Takeover
Bob Grant | Mar 22, 2016
Their $1.5 billion bid, which topped Thermo Fisher Scientific’s $1.3 billion offer for the genetic analysis company, was rejected.
Abbott Acquires Diagnostics Firm
Abbott Acquires Diagnostics Firm
Kerry Grens | Feb 2, 2016
In a deal worth $5.8 billion, Abbott Laboratories is buying medical test–maker Alere.
Shire to Buy Baxalta for $32 Billion
Shire to Buy Baxalta for $32 Billion
Tracy Vence | Jan 11, 2016
The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.
Thermo Fisher to Acquire Affymetrix
Thermo Fisher to Acquire Affymetrix
Tracy Vence | Jan 11, 2016
The boards of both companies have agreed to a $1.3 billion deal, which is subject to Affymetrix shareholder approval.